These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 8826565)

  • 1. Dual calcium-channel blocker therapy in the treatment of hypertension.
    Saseen JJ; Carter BL
    Ann Pharmacother; 1996; 30(7-8):802-10. PubMed ID: 8826565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of dual calcium channel blockade for the treatment of hypertension: a meta-analysis.
    Alviar CL; Devarapally S; Nadkarni GN; Romero J; Benjo AM; Javed F; Doherty B; Kang H; Bangalore S; Messerli FH
    Am J Hypertens; 2013 Feb; 26(2):287-97. PubMed ID: 23382415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension.
    Flynn JT; Pasko DA
    Pediatr Nephrol; 2000 Dec; 15(3-4):302-16. PubMed ID: 11149130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.
    Opie LH; Yusuf S; Kübler W
    Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.
    Opie LH
    Am J Hypertens; 1997 May; 10(5 Pt 1):565-77. PubMed ID: 9160770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
    Bulpitt CJ; Palmer AJ; Beevers DG; Coles EC; Ledingham JG; Petrie JC; Webster J
    J Hum Hypertens; 1997 Apr; 11(4):205-11. PubMed ID: 9185024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose calcium channel blocker (CCB) monotherapy vs combination therapy of standard-dose CCBs and angiotensin receptor blockers for hypertension: a meta-analysis.
    He T; Liu X; Li Y; Liu XY; Wu QY; Liu ML; Yuan H
    J Hum Hypertens; 2017 Feb; 31(2):79-88. PubMed ID: 27511478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.
    Makarounas-Kirchmann K; Glover-Koudounas S; Ferrari P
    Clin Ther; 2009 Aug; 31(8):1652-63. PubMed ID: 19808126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nondihydropyridine Calcium Channel Blockers for the Treatment of Proteinuria: A Review of the Literature.
    Steuber TD; Lee J; Holloway A; Andrus MR
    Ann Pharmacother; 2019 Oct; 53(10):1050-1059. PubMed ID: 30966785
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
    Onoda JM; Nelson KK; Taylor JD; Honn KV
    Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel blockers: monotherapy and dual therapy considerations in the treatment of hypertension.
    Sica DA
    Am J Cardiovasc Drugs; 2007; 7 Suppl 1():1-3. PubMed ID: 19847946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy.
    Oparil S; Weber M
    Postgrad Med; 2009 Mar; 121(2):25-39. PubMed ID: 19332960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
    Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
    Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers in cardiovascular pharmacotherapy.
    Godfraind T
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.
    Major TC; Dhamija S; Black N; Liachenko S; Morenko B; Sobocinski G; Okerberg C; Tinholt P; Madore S; Kowala MC
    J Pharmacol Exp Ther; 2008 Jun; 325(3):723-31. PubMed ID: 18326812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal treatment for calcium channel blocker poisoning: systematic review and recommendations from the EXTRIP workgroup.
    Wong A; Hoffman RS; Walsh SJ; Roberts DM; Gosselin S; Bunchman TE; Kebede S; Lavergne V; Ghannoum M;
    Clin Toxicol (Phila); 2021 May; 59(5):361-375. PubMed ID: 33555964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High blood pressure and calcium antagonism.
    Palma-Gámiz JL
    Cardiology; 1997; 88 Suppl 1():39-46. PubMed ID: 9118167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.